FDA recall D-0646-2025

Fagron Compounding Services · Class II · drug

Product

bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226

Reason for recall

Lack of Assurance of Sterility

Distribution

USA nationwide.

Key facts

Status: Ongoing
Initiation date: 2025-08-29
Report date: 2025-09-24
Voluntary/Mandated: Voluntary: Firm initiated
Location: Wichita, KS, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0646-2025